The article features oncologist James Berenson, MD, of the Berenson Cancer Center in California, who warns of the risk of "over-treating" patients with multiple myeloma. It has been reported that some hematologists strive to achieve as low a residual disease rate as possible (minimal residual disease). In this context, Berenson uses the metaphor of "people taking a hammer from patients" to point out the aggressiveness of some treatment approaches. The text suggests that efforts to maximally suppress the disease may lead to very intensive treatment regimens. The article is part of MedPage Today's "What We Heard This Week" column, which collects prominent statements from medical professionals. The given excerpt does not contain specific statistical data or results of a clinical study.